BSE Live
Nov 06, 16:01Prev. Close
153.85
Open Price
155.00
Bid Price (Qty.)
151.00 (1)
Offer Price (Qty.)
152.10 (5)
NSE Live
Nov 06, 15:43Prev. Close
153.77
Open Price
153.77
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
151.98 (4)
| Key Financial Ratios of Bliss GVS Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 8.95 | 7.22 | 5.53 | 5.73 | 6.36 | |
| Diluted EPS (Rs.) | 8.95 | 7.22 | 5.53 | 5.73 | 6.36 | |
| Cash EPS (Rs.) | 9.81 | 7.77 | 6.08 | 6.28 | 6.93 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 66.21 | 58.49 | 52.49 | 47.66 | 41.89 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 66.21 | 58.49 | 52.49 | 47.66 | 41.89 | |
| Dividend / Share(Rs.) | 0.50 | 1.00 | 1.00 | 0.60 | 0.50 | |
| Revenue from Operations/Share (Rs.) | 42.85 | 41.36 | 28.88 | 33.74 | 31.64 | |
| PBDIT/Share (Rs.) | 13.30 | 12.50 | 9.64 | 10.63 | 11.55 | |
| PBIT/Share (Rs.) | 12.44 | 11.94 | 9.09 | 10.08 | 10.99 | |
| PBT/Share (Rs.) | 11.80 | 11.64 | 8.42 | 9.20 | 9.72 | |
| Net Profit/Share (Rs.) | 8.95 | 7.22 | 5.53 | 5.73 | 6.36 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 31.03 | 30.21 | 33.38 | 31.49 | 36.51 | |
| PBIT Margin (%) | 29.03 | 28.87 | 31.48 | 29.87 | 34.72 | |
| PBT Margin (%) | 27.53 | 28.13 | 29.15 | 27.27 | 30.70 | |
| Net Profit Margin (%) | 20.89 | 17.44 | 19.13 | 16.99 | 20.10 | |
| Return on Networth / Equity (%) | 13.52 | 12.33 | 10.53 | 12.02 | 15.18 | |
| Return on Capital Employed (%) | 17.59 | 19.12 | 16.83 | 20.21 | 14.45 | |
| Return on Assets (%) | 10.79 | 10.11 | 8.21 | 8.87 | 11.22 | |
| Total Debt/Equity (X) | 0.10 | 0.11 | 0.16 | 0.15 | 0.14 | |
| Asset Turnover Ratio (%) | 51.68 | 57.97 | 42.92 | 52.23 | 55.82 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 5.13 | 6.28 | 4.21 | 3.65 | 2.85 | |
| Quick Ratio (X) | 4.65 | 5.69 | 3.92 | 3.47 | 2.68 | |
| Inventory Turnover Ratio (X) | 7.30 | 7.78 | 7.49 | 12.40 | 14.87 | |
| Dividend Payout Ratio (NP) (%) | 13.43 | 13.85 | 10.85 | 10.45 | 7.85 | |
| Dividend Payout Ratio (CP) (%) | 12.26 | 12.86 | 9.87 | 9.54 | 7.21 | |
| Earnings Retention Ratio (%) | 86.57 | 86.15 | 89.15 | 89.55 | 92.15 | |
| Cash Earnings Retention Ratio (%) | 87.74 | 87.14 | 90.13 | 90.46 | 92.79 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,024.58 | 1,830.01 | 2,032.75 | 1,809.92 | 1,312.79 | |
| EV/Net Operating Revenue (X) | 2.32 | 4.29 | 6.82 | 5.20 | 4.02 | |
| EV/EBITDA (X) | 7.47 | 14.20 | 20.44 | 16.51 | 11.02 | |
| MarketCap/Net Operating Revenue (X) | 2.35 | 4.35 | 6.76 | 5.23 | 4.01 | |
| Retention Ratios (%) | 86.56 | 86.14 | 89.14 | 89.54 | 92.14 | |
| Price/BV (X) | 1.52 | 3.08 | 3.72 | 3.70 | 3.03 | |
| Price/Net Operating Revenue | 2.35 | 4.35 | 6.76 | 5.23 | 4.01 | |
| Earnings Yield | 0.09 | 0.04 | 0.03 | 0.03 | 0.05 |
30.07.2025
Bliss GVS Consolidated June 2025 Net Sales at Rs 207.47 crore, up 12.97% Y-o-Y
30.07.2025
Bliss GVS Standalone June 2025 Net Sales at Rs 163.36 crore, up 9.67% Y-o-Y
13.05.2025
Bliss GVS Standalone March 2025 Net Sales at Rs 156.00 crore, down 4.77% Y-o-Y
13.05.2025
Bliss GVS Consolidated March 2025 Net Sales at Rs 197.99 crore, down 0.07% Y-o-Y